# Ajay K. Kakkar

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/ajay-k-kakkar/

## Facts

| Field | Value |
| --- | --- |
| Citations | 41,003 |
| Field | Venous Thromboembolism Diagnosis and Management |
| h-index | 72 |
| i10-index | 174 |
| Last Known Institution | Thrombosis Research Institute |
| OpenAlex ID | https://openalex.org/A5109340689 |
| ORCID iD | https://orcid.org/0000-0003-4054-606X |
| Works | 310 |

## Researcher papers

- [Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-stable-cardiovascular-disease/)
- [Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial](https://scholariq.org/papers/rivaroxaban-with-or-without-aspirin-in-patients-with-stable-peripheral-or/)
- [Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer](https://scholariq.org/papers/rivaroxaban-for-thromboprophylaxis-in-high-risk-ambulatory-patients-with-cancer/)
- [2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer](https://scholariq.org/papers/2019-international-clinical-practice-guidelines-for-the-treatment-and/)
- [Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin](https://scholariq.org/papers/safety-of-proton-pump-inhibitors-based-on-a-large-multi-year-randomized-trial-of/)
- [2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19](https://scholariq.org/papers/2022-international-clinical-practice-guidelines-for-the-treatment-and/)

## Researcher topics

- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management-2/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Blood Coagulation and Thrombosis Mechanisms](https://scholariq.org/topics/blood-coagulation-and-thrombosis-mechanisms/)
- [Central Venous Catheters and Hemodialysis](https://scholariq.org/topics/central-venous-catheters-and-hemodialysis/)

## Researcher university

- [Thrombosis Research Institute](https://scholariq.org/institutions/thrombosis-research-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.